Insider Transactions in Q1 2023 at G1 Therapeutics, Inc. (GTHX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2023
|
John V. Umstead Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+45.92%
|
-
|
|
Jan 05
2023
|
James S. Hanson General Counsel |
SELL
Open market or private sale
|
Direct |
729
-1.74%
|
$3,645
$5.41 P/Share
|
|
Jan 05
2023
|
Rajesh Malik Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
729
-0.7%
|
$3,645
$5.41 P/Share
|
|
Jan 05
2023
|
Terry L Murdock Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
729
-1.96%
|
$3,645
$5.41 P/Share
|
|
Jan 05
2023
|
Jennifer K. Moses CFO |
SELL
Open market or private sale
|
Direct |
729
-1.25%
|
$3,645
$5.41 P/Share
|
|
Jan 04
2023
|
John E. (Jack) Bailey Jr. President and CEO |
SELL
Open market or private sale
|
Direct |
5,607
-1.99%
|
$28,035
$5.58 P/Share
|
|
Jan 04
2023
|
James S. Hanson General Counsel |
SELL
Open market or private sale
|
Direct |
1,639
-3.77%
|
$8,195
$5.58 P/Share
|
|
Jan 04
2023
|
Rajesh Malik Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,639
-1.56%
|
$8,195
$5.58 P/Share
|
|
Jan 04
2023
|
Andrew Perry Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
820
-3.71%
|
$4,100
$5.58 P/Share
|
|
Jan 04
2023
|
Terry L Murdock Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,639
-4.22%
|
$8,195
$5.58 P/Share
|
|
Jan 04
2023
|
Jennifer K. Moses CFO |
SELL
Open market or private sale
|
Direct |
1,639
-2.72%
|
$8,195
$5.58 P/Share
|
|
Jan 03
2023
|
John E. (Jack) Bailey Jr. President and CEO |
SELL
Open market or private sale
|
Direct |
32,019
-10.2%
|
$160,095
$5.85 P/Share
|
|
Jan 03
2023
|
John E. (Jack) Bailey Jr. President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
80,700
+20.45%
|
-
|
|
Jan 03
2023
|
James S. Hanson General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
17,900
+29.17%
|
-
|
|
Jan 03
2023
|
Mark Avagliano Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,600
+32.83%
|
-
|
|
Jan 03
2023
|
Rajesh Malik Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,900
+14.55%
|
-
|
|
Jan 03
2023
|
Andrew Perry Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,100
+42.12%
|
-
|
|
Jan 03
2023
|
Terry L Murdock Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,900
+31.57%
|
-
|
|
Jan 03
2023
|
Jennifer K. Moses CFO |
BUY
Grant, award, or other acquisition
|
Direct |
22,300
+27.03%
|
-
|